Skip to main content

CVS Health expands access to non-prescription naloxone to five additional states


WOONSOCKET, R.I. - CVS Health on Thursday announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription.  

In total, CVS Pharmacy patients in 36 states now have increased access to the opioid overdose-reversal drug.  

"Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery," stated Tom Davis, VP pharmacy professional practices at CVS Pharmacy. "By establishing a physician-authorized standing order that allows our pharmacies to dispense naloxone to patients without an individual prescription, we strengthen our commitment to helping the communities we serve begin to address the challenges of prescription drug abuse."

"Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic – along with effective prevention, treatment and enforcement," said Michael Botticelli, director of National Drug Control Policy. "Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug."

With the addition of the five new states where CVS Pharmacy locations began dispensing naloxone to patients without a prescription this week, CVS Pharmacy locations in the following 36 states now offer naloxone: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.  CVS Health also plans to further expand its naloxone program to other states in the coming months.

This ad will auto-close in 10 seconds